Despite pharma-funded study, statins still risky as ever

I’m not sure that Dr. Kausik Ray has ever met a person he doesn’t think should start up on a statin immediately!

This professor at the Imperial College London has just come out with his latest study, which is aimed at healthy guys (and gals) with elevated cholesterol who don’t have heart disease.

According to Dr. Ray, they need statin therapy, too!

And as the good doctor travels around the world (having visited places this summer as far apart as Taipei, Philadelphia, and Brazil) spreading the statin word and soothing worries about these risky drugs, lots of people may fall prey to what Big Pharma has been trying to do for years now.

And that’s to get every man, woman, and child popping these meds like candy.

But if you’re still on the fence about taking one of these drugs, there are some vital facts you need to know before you let Dr. Ray and his widely publicized research convince you to take the plunge.

The ‘magic threshold’
For his latest research, Professor Statin says that giving these drugs to men with no health issues, other than high LDL cholesterol numbers, will lower the odds of them dying from heart disease.

Actually, for men and women of any age — even in their 30s — if your cholesterol is “high,” it’s high time for a statin, Ray says.

It probably won’t surprise you that Ray’s new study got a helping hand from the Big Pharma trio of Sanofi, Bristol-Myers Squibb, and Sankyo. But for Ray, that’s pretty much business as usual.

His pharma friends, from whom he receives “personal fees” and “consulting” payments, number among the biggest in the drug world and include Pfizer, AstraZeneca, and Eli Lily.

Unfortunately, what that will mean is that large numbers of people will come down with new-onset diabetes.

Of course, Dr. Ray has an answer for that.

If you should become diabetic while on one of these drugs, he says, that’s because you were “on a trajectory” for the disease… and you’ve simply crossed that “magic threshold.”

However, some major independent research has proven otherwise.

In one big study we told you about two years ago, researchers from the University of Texas Southwest wanted to see what effect statins would have on generally healthy people. So, they analyzed records from the Tricare health system for active-duty and retired military men and women as well as their families.

After going over the data of what they called “a very healthy population” of 26,000 individuals who didn’t have heart disease, diabetes, or any other chronic health condition for that matter, they came to a shocking realization.

Once someone starts up on a statin, they’re upping their odds of developing new-onset diabetes by a whopping 87 percent — nearly doubling the estimate of 46 percent that researchers had previously believed to be the case, which would be bad enough.

But it seems that what Dr. Ray would like us to believe is that the vast majority of healthy people are all going to end up diabetic, anyway. So… what’s the big deal?

Of course, diabetes is only one consequence of popping these pills.

Other all-too-common adverse reactions include severe muscle weakness and fatigue. But if one of these drugs drains your energy and zaps your interest in exercise, Ray argues, that’s okay, because “Fatigue is reversible and not fatal.”

But what about the brain fog… depletion of CoQ10 (something that could actually lead to heart failure)… and even hardening of the arteries?

Of course, Dr. Ray is hoping to convince you that all those other findings are nonsense and that his new research somehow “legitimizes” those statins-for-all recommendations.

But the statin bubble has been burst so many times now I’ve lost count. One respected researcher has said that statins merely provide an “illusion” of heart protection.

And if anything, Ray’s approach speaks volumes about the fact that more people than ever are finally getting wise to the statin scam!

“Statins DO work: Cheap pills slash heart attack and stroke deaths by 28% in men, 20-year study finds” Sophie Borland, September 6, 2017, The Daily Mail, dailymail.co.uk